Evidence map›Paper›PMID 31395804›Full record

ArticleInternational journal of molecular sciences2019

CD34 Identifies a Subset of Proliferating Microglial Cells Associated with Degenerating Motor Neurons in ALS.

Mariángeles Kovacs, Emiliano Trias, Valentina Varela, Sofia Ibarburu, Joseph S Beckman, Ivan C Moura, Olivier Hermine, Peter H King, Ying Si, Yuri Kwon and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. A Nitroalkene Benzoic Acid Derivative Targets Reactive Microglia and Prolongs Survival in an Inherited Model of ALS via NF-κB Inhibition.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Mariángeles KovacsInstitut Pasteur de Montevideo, Montevideo 11400, Uruguay.
Emiliano TriasInstitut Pasteur de Montevideo, Montevideo 11400, Uruguay.
Valentina VarelaInstitut Pasteur de Montevideo, Montevideo 11400, Uruguay.
Sofia IbarburuInstitut Pasteur de Montevideo, Montevideo 11400, Uruguay.
Joseph S BeckmanLinus Pauling Institute, Department of Biochemistry and Biophysics, Environmental Health Sciences Center, Oregon State University, Corvallis, OR 97331, USA.
Ivan C MouraImagine Institute, Hôpital Necker, 75015 Paris, France.
Olivier HermineImagine Institute, Hôpital Necker, 75015 Paris, France.
Peter H KingDepartment of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0000-0001-9391-7464
Ying SiDepartment of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Yuri KwonDepartment of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Luis BarbeitoInstitut Pasteur de Montevideo, Montevideo 11400, Uruguay. barbeito@pasteur.edu.uy.ORCID 0000-0001-7187-511X
Institut Pasteur de Montevideo · UYUniversity of Alabama at Birmingham · USDélégation Paris 5 · FROregon State University · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
Smad Signaling in Skeletal Muscle as a Biomarker of Disease Progression in ALSR01NS092651 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KING, PETER H · 2016 to 2020
$1.6M
FGF23: a novel biomarker in ALS and moreR21NS111275 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KING, PETER H · 2019 to 2019
$422k
BLRD VA I01 BX004419NCI NIH HHS P30 CA013148NINDS NIH HHS R01 NS092651NINDS NIH HHS R21 NS111275
6 · The paper itself

Abstract

Amyotrophic lateral sclerosis (ALS) is characterized by degeneration of upper and lower motor neurons accompanied by proliferation of reactive microglia in affected regions. However, it is unknown whether the hematopoietic marker CD34 can identify a subpopulation of proliferating microglial cells in the ALS degenerating spinal cord. Immunohistochemistry for CD34 and microglia markers was performed in lumbar spinal cords of ALS rats bearing the SOD1

Indexed as

Amyotrophic Lateral SclerosisAnimalsAntigens, CD34Cell ProliferationCells, CulturedHumansMaleMicrogliaMotor NeuronsPoint MutationProtein FoldingRatsSpinal CordSuperoxide Dismutase-1Antigens, CD34Superoxide Dismutase-1amyotrophic lateral sclerosisCD34microgliamisfolded SOD1motor neurons

Identifiers

PMID31395804
PMCPMC6720880
OpenAlexW2968132587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.